In the last trading session, 1.25 million Prothena Corporation plc (NASDAQ:PRTA) shares changed hands as the company’s beta touched 0.02. With the company’s per share price at $7.29 changed hands at -$0.11 or -1.49% during last session, the market valuation stood at $392.40M. PRTA’s last price was a discount, traded about -248.7% off its 52-week high of $25.42. The share price had its 52-week low at $6.47, which suggests the last value was 11.25% up since then.
Analysts gave the Prothena Corporation plc (PRTA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 1 out of 15 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended PRTA as a Hold, 11 felt it is a Buy and 0 rated the stock as Underweight.
Prothena Corporation plc (NASDAQ:PRTA) trade information
Instantly PRTA was in red as seen at the end of in last trading. With action -3.95%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -47.36%, with the 5-day performance at -3.95% in the red. However, in the 30-day time frame, Prothena Corporation plc (NASDAQ:PRTA) is -21.61% down.
The consensus price target for the stock as assigned by Wall Street analysts is 56, meaning bulls need an upside of 86.98% from its current market value. According to analyst projections, PRTA’s forecast low is 24 with 98 as the target high. To hit the forecast high, the stock’s price needs a -1244.31% plunge from its current level, while the stock would need to soar -229.22% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -3.15%. The 2025 estimates are for Prothena Corporation plc earnings to decrease by -54.63%, but the outlook for the next 5-year period is at -9.83% per year.
PRTA Dividends
Prothena Corporation plc is expected to release its next quarterly earnings report in June.
FMR LLC holds the second largest percentage of outstanding shares, with 15.0012% or 8.07 million shares worth $166.48 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . With 4.22 shares estimated at $30.76 million under it, the former controlled 7.84% of total outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held about 4.31% of the shares, roughly 2.32 shares worth around $16.9 million.
